Document 0977 DOCN M94A0977 TI A needleless intravenous system for blood draw. DT 9412 AU Descamps JM; Bortolotti V; Damade R; Fleury L; Rouveix E; Verdon R; Bouvet E; GERES, Hopital Bichat, Paris, France. SO Int Conf AIDS. 1994 Aug 7-12;10(2):237 (abstract no. PB0963). Unique Identifier : AIDSLINE ICA10/94371598 AB OBJECTIVE: 10% of needlestick injuries occuring in healthcare settings are due to blood draw. In a pilot multicenter randomised study designed to find out the interest of a new reflux valve with a rubber port (RVRP)* compared to those of the line equipped with a 3 way stopcok we studied biological assays from blood samples drawn from the same patient both by phlebotomy and via the RVRP locked on the end of an angiocatheter. METHOD: 42 patients (with inform consent) hospitalized in 5 medical wards who had the RVRP and for whom a blood draw was scheduled had had 84 assays. For patients with a saline lock or IV line, the first 2 ml of blood taken were disregarded. RESULTS: Table 1 shown the value of the biological assays analysed from blood obtained by phlebotomy and those drawn via the RVRP. TABULAR DATA, SEE ABSTRACT VOLUME. DISCUSSION AND CONCLUSION: For some of the biological parameters choosed for the study we find out a significative difference. This difference has actually any clinical or biological value or impact. More comprehensive studies could be performed for other biological values (haemotological one by ex). No exposure to blood was reported by the nurses during the study and no sepsis due to the IV line equipped with the RVRP was noticed. After this study we suggest that when the patient has an angiocatheter this way for doing blood draw should be used. It is needle safe and it is confortable for the patients. DE Blood Specimen Collection/*METHODS Bloodletting Comparative Study Human Needlestick Injuries/PREVENTION & CONTROL Pilot Projects Punctures Support, Non-U.S. Gov't CLINICAL TRIAL MEETING ABSTRACT MULTICENTER STUDY RANDOMIZED CONTROLLED TRIAL SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).